Urgent.News

600+ sources. One page. See who else covered it.

Editions

Business

Microenterprises multiply job creation by five up to July

Employment in companies with fewer than ten workers grew by almost 2% year-on-year in July, compared to stagnation a year earlier.

Translated from Spanish Read in Spanish

Microenterprises multiply job creation by five up to July

Spain is a country of small and medium-sized enterprises. 84% of companies have between 1 and 9 employees and often the owners of these companies complain of being the ugly duckling of the economy: they claim to be suffocated by the increase in costs and the weight of bureaucratic burdens. But at least in the last year, they have been showing enormous dynamism.

According to the latest statistics of companies registered with the Social Security, those with fewer than ten employees have recorded a year-on-year increase in employment in July of 1.9%. This is equivalent to adding 56,000 workers compared to a year ago. And it means multiplying by more than five the creation of employment compared to the records of July 2025, when they barely showed a growth of 0.3% in posts.

Translated by urgent.news. Machine-written — may contain errors; check the original before relying on it.

Read the original at elpais.com →

More in Business

Korea Trade Insurance Backs Samsung C&T Subsidiary

Amid rapid changes in the export environment for domestic companies due to strengthening carbon regulations in Europe, the Korea Trade Insurance Corporation has stepped up to provide customized…

  • Korea Trade Insurance Corp. offers 25 million euro insurance for Samsung C&T subsidiary.
  • Insurance serves as collateral for bank purchase of trade receivables.
  • Non-recourse condition eases subsidiary's financial burden.

Biosolution Signs Cartilife Supply Deal in China

Biosolution is accelerating its efforts to target the Chinese market, spearheaded by its autologous chondrocyte therapy ‘Cartilife’.Biosolution announced on August 13 that it signed a final…

  • Hospital can perform Cartilife therapy to 1,000 patients annually with GMP facilities.
  • Biosolution CEO sees partnership as turning point for local revenue generation in China.

More from Thursday 13 August →